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This article presents a case series of n = 21 models of fetal cardiovascular anatomies
obtained from post mortem microfocus computed tomography (micro-CT) data. The
case series includes a broad range of diagnoses (e.g., tetralogy of Fallot, hypoplastic
left heart syndrome, dextrocardia, double outlet right ventricle, atrio-ventricular septal
defect) and cases also had a range of associated extra-cardiac malformations (e.g.,
VACTERL syndrome, central nervous system anomalies, renal anomalies). All cases
were successfully reconstructed from the microfocus computed tomography data,
demonstrating the feasibility of the technique and of the protocols, including in-house
printing with a desktop 3D printer (Form2, Formlabs). All models were printed in 1:1
scale as well as with the 5-fold magnification, to provide insight into the intra-cardiac
structures. Possible uses of the models include education and training.
Keywords: 3D printing, microfocus computed tomography, fetal heart, congenital heart disease, fetal cardiology,
prenatal diagnosis
INTRODUCTION
Congenital heart defects are the most frequent congenital malformations. Advances in prenatal
medicine allow early diagnosis, starting from the eleventh week of gestation (1, 2). Confirming
the cardiac malformation after termination of pregnancy is essential for medical knowledge
and familial counseling. Conventional autopsy is the gold standard technique for post mortem
confirmation of congenital heart disease (CHD) but it lacks diagnostic power especially in
challenging samples, such as cases of termination of pregnancy and of low dimension/weight (3, 4).
In recent years, radiologic tools are becoming valid alternatives to conventional autopsies, in light
of their non-destructive approach and high-resolution imaging capabilities (5–12). By using X-ray
source on contrast-enhanced samples, post mortem microfocus computed tomography (micro-
CT) can reach a spatial resolution of voxel sizes below 1 micron (i.e., <0.001mm), thus allowing
the evaluation of cardiac structures also in challenging specimens (5–9). Iodine preparation of
the sample is necessary in order to create contrast between different cardiac soft tissues, that are
otherwise not distinguishable (6).
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Three-dimensional (3D) printing in CHD is gaining
increasing interest in the clinical and bioengineering
communities alike, considering the breath of its applications.
These include medical education, surgical, and catheter-based
procedural individualized planning, and manufacturing research
for device innovation (13–16). At present, applications of 3D
printing in fetal cardiology are limited, yet the technique
is appealing as precise visualization of small structures
is essential to achieve a correct diagnosis, even in a very
early in pregnancy. Pioneering work coming from in utero
3D echocardiography/magnetic resonance imaging (MRI)
(17, 18) and from post mortem micro-CT (19) have been
recently published.
Based on these early experiences, here we present a feasibility
study of 3D printing normal fetal hearts and fetal hearts with
CHD from micro-CT datasets, resulting in a case series of
different diagnoses. The focus of the article is on technical issues
of the imaging and printing processes.
MATERIALS AND METHODS
Selection of Cases
Post mortem micro-CT followed by conventional autopsy
is offered to all patients referred to our Center for fetal
echocardiography who decided for termination of pregnancy
(below 21+6 week of gestation, according to Italian Law) for
either fetal cardiac anomalies or extra-cardiac malformations.
Samples are managed according to previous described procedure
(20). Post mortem micro-CT acquisitions are performed using a
micro-CT SkyScan 1176 scanner (Bruker, Kontich, Belgio). Here
we present the experience of consecutive cases collected between
July 2016 and December 2018.
Micro-CT Imaging Protocol
Before performing micro-CT scans, the specimens were stained
by immersion in Lugol solution 15% (10 g potassium iodide and
5 g iodine in 100ml water) for 24 h. Subsequently, the heart was
washed with alcohol to remove free iodine, blotted dry, and
scanned All scans were performed with a Bruker Skyscan 1176
micro-CT scanner (Bruker, Brussels Kontich, Belgium) with a
gantry diameter of 68mm. Fixed acquisition times of 25min were
used for resolutions at 9µm and 6min for resolution at 18µm.
The exposure time was 1,050ms, respectively, the voltage was
80 kV in all cases, the current was 300 µA, and the rotation
step 0.30◦. The projection data were corrected for distortion
and reconstructed by adjusting, smoothing and correction of
ring artifact and beam hardening. The reconstructed isotropic
voxel size was 9. Images were reconstructed with the scanner
software (NRecon 1.6.6.0, Skyscan, Brucker micro-CT, Belgium)
and converted to DICOM format for analysis. The time for
reconstruction ranged from 2 to 60min, depending on the
volume of the sample. Acquired images were rendered and
exported as a three-dimensional (3D) volume. Post-processing
analysis was performed using CTVox volume rendering 64
bit version, DATAVIEWER 64 bit version (Bruker, Kontich,
Belgium), and Horos (v 2.4) software (free and open source code
software at Horosproject.org).
3D Printing Protocol
The micro-CT data served as the input for the 3D printing
process. Images were imported in commercial software (Mimics
v.21, Materialize, Leuven, Belgium) and reconstructed following
steps of thresholding, region growing and semi-automatic image
segmentation with manual editing where required, and the final
volume meshes were exported as.stl files. All models were 1:1 in
size as well as scaled with a 5-fold factor to provide more insight
such small-sized cardiovascular structures. Each case was thus
printed twice, in the two sizes. Prior to printing, models’ surfaces
were checked, and a scaffold was added (PreForm, Formlabs,
. . . ). Models were printed in-house using a rigid white resin
(Form2, Formlabs) and cleaned manually through standard steps
of isopropanol washing and curing with final manual removal of
the model’s scaffold.
RESULTS
A total of n = 21 cases were collected and reconstructed.
Anamnestic data are summarized in Table 1. Samples consisted
in heart (19/21, 90%) and heart-lungs (2/21, 10%). Mean
gestational age at fetal echocardiography was 15.0 ± 2.9 weeks
(range: 12–21 weeks). Mean gestational age at termination of
pregnancy was 16.0 ± 3.0 weeks (range: 12–22 weeks). Overall,
18/21 (86%) cases suffered from cardiac anomalies, 15 (83%)
of which were complex CHD. 13/21 (62%) cases had abnormal
karyotype at invasive testing (chorionic villus sampling or
amniocentesis). 10/21 (48%) cases had associated extra-cardiac
malformations (VACTERL syndrome, central nervous system
anomalies including omphalocele and other anomalies of the
posterior cranial fossa, cystic hygroma, cleft lips, renal anomalies
including ptosis and polycystic kidneys, skeletal anomalies
including anomalies of the arms, legs, vertebral column, and
ribcage). Mean longitudinal diameter was 1.05 ± 0.37 cm (range
0.4–1.7 cm).Mean transverse diameter was 0.95± 0.36 cm (range
0.4–1.8 cm). Mean weight was 0.88 ± 1.06 g (range: 0.39–4 g).
Table 2 summarizes micro-CT acquisition properties.
All cases were successfully reconstructed, demonstrating the
feasibility of the technique and of the protocols, including in-
house printing. Examples of 3D reconstructions are provided
in Figure 1. Examples of 3D printed models are provided in
Figure 2. When printed with the 5-fold magnification, models
were also cut in a four-chamber view equivalent section, to
provide insight into the intra-cardiac structures.
DISCUSSION AND CONCLUSION
Little is known about the feasibility of 3D printing from micro-
CT datasets in the field of fetal cardiology. Traditionally, 3D
printing of cardiovascular models relies on cardiac CT and
MRI datasets of pediatric and adult human hearts in different
settings according to established methodologies (12). Accuracy
of postmortem micro-CT in ex-vivo evaluation of human fetal
heart is validated.More recently, proof of principle experiences in
3D printing from micro-CT of human specimens in craniofacial
surgery, placental imaging, archeological remains, bone imaging,
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TABLE 1 | Summary of cases included for 3D modeling, including main diagnosis, gestational age (GA) at diagnosis, and termination of pregnancy (TOP), karyotype,
extra-cardiac anomalies, and dimensional assessment.
Prenatal data Macroscopic data
ID GA at
diagnosis
(week+days)
Diagnosis Kariotype Extra-cardiac
anomalies
GA at top
(week+days)
Sample Longitudinal
diameter (cm)
Transversal
diameter (cm)
Weight pre
micro-CT (g)
1 20 Posterior malalignment
VSD, aortic hypoplasia,
hypoplastic aortic arch
46, XX VACTERL
syndrome
20+4 Heart 1.50 1.30 3.370
2 16+2 TOF 46, XX Frontal bossing,
hands anomalies
18+6 Heart 1.50 1.30 3.070
3 20+2 Large ASD, large VSD,
borderline LV, aortic
hypoplasia
46, XY, del
(11)(q23.3)
Labial cleft,
kidney, and
hands anomalies
20+4 Heart 1.50 1.20 3.330
4 16+1 VSD 47, XY, +21 – 16+5 Heart 1.00 0.80 1.320
5 21+2 HLHS (mitral
atresia/aortic atresia)
– – 21+6 Heart 1.70 1.80 4.000
6 16+2 PA-VSD/truncus
arteriosus
47, XY, +9 IUGR, CNS
anomalies
16+3 Heart 1.10 0.80 0.650
7 12+4 AVSD 47, XY, +21 – 13+6 Heart 0.60 0.50 0.390
8 14+3 AVSD/large VSD inlet 47, XY, +21 – 14+3 Heart 1.00 0.70 0.490
9 17+2 TOF – Omphalocele 18+2 Heart 1.40 1.30 1.800
10 13+2 AVSD 47, XY, +21 – 13+4 Heart 0.50 0.50 0.400
11 14 Dextrocardia, large
conoventricular VSD,
probable DORV,
side-by-side great
arteries
47, XXX CNS and kidney
anomalies
17+1 Heart 0.80 0.80 0.687
12 17+4 Normal 46, XX Fetal hydrops,
pleural, and
abdominal
effusion
17+5 Heart 0.90 0.90 0.641
13 13+3 Normal – – 16+0 Heart 1.00 1.00 0.821
14 12+5 AVSD/ partial AVSD
(inlet VSD+little ostium
primum ASD)
47, XY, +21 – 12+5 Heart 0.40 0.40 0.687
15 12+5 AVSD 47, XX, +21 – 15 Heart 1.20 1.20 0.641
16 16+4 Muscular VSD, right
aortic arch
47, XX, +21 – 17+5 Heart +
Lungs
1.50 1.50 0.821
17 19 Normal – Fetal hydrops,
cystic hygroma,
bilateral pleural
effusion
12+6 Heart 0.80 0.80 0.641
18 20 AVSD 47, XY, +21 Acrania 14+6 Heart +
Lungs
1.10 1.10 0.821
19 21 AVSD 47, XX, +21 – 12+6 Heart 0.687
20 22 TOF/anterior
malalignment VSD
47, XX, +21 – 13+3 Heart 0.641
21 23 Inlet VSD – – 21+3 Heart 0.821
and cardiac anatomy has been presented (19). Shelmerdine
et al. reported one example of 3D printing from micro-CT of
an human fetal heart of 16 weeks of gestation, demonstrating
that both main cardiac segments (atria, ventricles, and great
vessels) and smaller component (cardiac valves, branching of the
pulmonary artery and aorta, papillary muscle, and ventricular
trabeculations) can be identified (19). There are any published
data concerning earlier gestational age and larger case series. Our
study complements these information on the feasibility of the
technique and presents a case series comprehensive of complex
cases of CHD, including hypoplastic left heart syndrome, double
outlet right ventricle and tetralogy of Fallot from early and
mid-gestational age (from 12 to 21 weeks of gestation). We
agree with Shelmerdine’s experience on feasibility and possible
utility of 3D printing of human fetal heart from micro-CT.
As compared to previous published projects, the novelty we
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TABLE 2 | Main settings for micro-CT acquisitions.
ID Top to micro-CT
(days)
Lugol % Lugol (h) Filter Resolution
(µm)
Energy
range (V)
Current
range (µA)
Rotational
step (◦)
1 68 25 72 Cu+Al 18 500 89 264
2 194 25 72 Cu+Al 18 500 89 264
3 260 25 72 Cu+Al 18 500 89 264
4 178 20 72 Cu+Al 18 500 89 264
5 21 25 72 Cu+Al 18 500 89 264
6 18 20 72 Al 0,5mm 18 210 50 500
7 16 20 72 Al 0,5mm 9 900 50 500
8 16 20 72 Al 0,5mm 18 210 50 500
9 17 25 72 Cu+Al 18 500 89 264
10 16 20 72 Al 0,5mm 9 900 50 500
11 247 20 72 Cu+Al 18 300 80 300
12 200 20 72 Cu+Al 18 300 80 300
13 200 20 72 Cu+Al 18 300 80 300
14 83 15 48 Al 0,5mm 18 210 50 500
15 80 30 72 Cu+Al 18 300 80 300
16 74 30 72 Cu+Al 18 300 80 300
17 67 20 48 Al 0,5mm 18 210 50 500
18 66 30 72 Cu+Al 18 300 80 300
19 33 15 48 Al 0,5mm 18 210 50 500
20 41 30 72 Cu+Al 18 300 80 300
21 19 25 72 Cu+Al 18 300 80 300
FIGURE 1 | Presentation of 3D models of all patients included in the case series, highlighting the wide range of morphologies (not to scale).
would like to demonstrate concerns the feasibility of micro-
CT in a larger population of normal and pathological hearts
with a wide range of gestational ages. The studied population
consists of both normal and abnormal fetal hearts. Whilst
the segmentation and printing processes are the same for
normal and pathologic specimens, reconstruction of complex
structures may require expert guidance in the identification
of anatomical features of interest. Moreover, the population
includes small samples (15/21 cases, 71%: weight ≤ 1 g; 9/21
cases, 43%: longitudinal and transverse diameter ≤ 1 cm) and
cases of low gestational age (10/21 cases, 48%: termination of
pregnancy before the 15 weeks of gestation). This enabled us
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FIGURE 2 | Example of 3D printed models for a range of cases with different diagnoses, including the 1:1 3D printed model as well as the corresponding 5-fold
scaled model for each case.
to demonstrate the feasibility of the process for both larger and
smaller samples.
We focused only on technical aspects. Educational, research,
and clinical implications remain to be addressed in the future and
are beyond the scope of presenting this case series.
Virtual and printed models are nowadays used for didactic
and research purposes in other areas of medicine, e.g., 3D
printing fetal brains (22). These models can potentially represent
a valuable resource for teaching fetal cardiac anatomy to medical
students and trainees as well, presenting both normal fetal
cardiovascular anatomy and congenital heart defects of different
complexity. Whilst this should be systematically assessed in the
context of cardiac morphology teaching, evidence is beginning
to suggest that accurate 3D printed replicas can improve the
teaching experience, reducing potential adverse reactions from
students (e.g., in relation to cultural or religious backgrounds)
and also holding the potential to show fetal development at
different stages, to illustrate its full progression (21). Educational
values of 3D printing models from micro-CT could play
even a more important role in our era, where early fetal
echocardiography is offered to high risk pregnancies since the
eleventh week of gestation. The possibility to visualize small
cardiac structure and to navigate into normal and pathological
fetal heart offered by micro-CT could facilitate interpretation
of echo images and, ultimately, improve medical knowledge.
Moreover, integration of different imaging modalities also opens
the door to research applications, which include 3D printing fetal
heart models indeed derived from fetal echocardiographic data
and integrated with 4D MRI flow information, which can also
represent a valuable platform for in vitro modeling (18). Future
application of 3D printed models could be related to familial
counseling, fetal diagnosis, and more individualized planning
of fetal and neonatal therapeutic strategies. On one hand,
counseling applications may be limited due to the potentially
confrontational and highly sensitive nature of the conversations
and the role of the model as a communication tool in this
context may potentially be counterproductive, as “reopening the
wound” in revisiting the clinical conversations that ultimately
led to terminating the pregnancy. On the other hand, 3D
models (even scaled-up) could be used during familial counseling
to facilitate familial awareness of fetal cardiac dimension and
anatomy. Though biological effect of X ray radiation limits the
in-vivo use of micro-CT and avoid patient-specific models, 3D
reconstruction of first/early second trimester cardiac structure
from micro-CT datasets is feasible. On the contrary, at present,
data from 3D fetal echocardiography acquired during the
first trimester has never been used to reconstruct and print
fetal heart.
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